OTC Markets EXMKT - Delayed Quote USD
SQZ Biotechnologies Company (SQZB)
0.0390
+0.0090
+(30.00%)
As of June 12 at 8:00:00 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 619.02k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CAPASSO RICHARD V Officer | Sale at price 0.34 per share. | Direct | 402 | Aug 15, 2022 |
| CAPASSO RICHARD Officer | Sale at price 3.33 per share. | Direct | 3,935 | Aug 15, 2022 |
| CAPASSO RICHARD V Officer | Stock Award(Grant) at price 0.32 per share. | Direct | 376 | Jun 30, 2022 |
| KNOPF LAWRENCE J General Counsel | Stock Award(Grant) at price 2.70 per share. | Direct | 4,011 | Jun 30, 2022 |
| SHAREI ARMON Chief Executive Officer | Stock Award(Grant) at price 2.70 per share. | Direct | 6,585 | Jun 30, 2022 |
| CAPASSO RICHARD Officer | Stock Award(Grant) at price 2.70 per share. | Direct | 3,198 | Jun 30, 2022 |
| JENSEN KLAVS F. PH.D. Director | Purchase at price 3.52 per share. | Direct | 50,428 | May 25, 2022 |
| SHAREI ARMON Chief Executive Officer | Conversion of Exercise of derivative security at price 1.81 per share. | Direct | 23,530 | Jan 12, 2022 |
| KNOPF LAWRENCE J General Counsel | Stock Award(Grant) at price 7.59 per share. | Direct | 3,446 | Dec 31, 2021 |
| SHAREI ARMON Chief Executive Officer | Stock Award(Grant) at price 7.59 per share. | Direct | 12,798 | Dec 31, 2021 |
| SCHULMAN AMY W. Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 2.02 - 4.59 per share. | Direct | 84,823 | Dec 22, 2021 |
| SHAREI ARMON Chief Executive Officer | Conversion of Exercise of derivative security at price 1.81 per share. | Direct | 19,999 | Dec 22, 2021 |
| SCHULMAN AMY W. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 10.88 - 10.94 per share. | Indirect | 40,367 | Dec 13, 2021 |
| SHAREI ARMON Chief Executive Officer | Conversion of Exercise of derivative security at price 1.81 per share. | Direct | 14,480 | Feb 26, 2021 |
| SHAREI ARMON Chief Executive Officer | Conversion of Exercise of derivative security at price 1.81 per share. | Direct | 4,525 | Jan 8, 2021 |
| SCHULMAN AMY W. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 16.00 per share. | Indirect | 4,000,000 | Nov 3, 2020 |
| SCHULMAN AMY W. Director and Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Nov 3, 2020 |
| POLARIS MANAGEMENT CO. VII, L.L.C Beneficial Owner of more than 10% of a Class of Security | Purchase at price 16.00 per share. | Indirect | 4,000,000 | Nov 3, 2020 |
| POLARIS MANAGEMENT CO. VII, L.L.C Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Nov 3, 2020 |
| TEMASEK HOLDINGS PRIVATE LIMITED Beneficial Owner of more than 10% of a Class of Security | Purchase at price 16.00 per share. | Indirect | 10,000,000 | Nov 3, 2020 |
| TEMASEK HOLDINGS PRIVATE LIMITED Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Nov 3, 2020 |
| INVUS PUBLIC EQUITIES ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 16.00 per share. | Indirect | 7,440,000 | Nov 3, 2020 |
| INVUS PUBLIC EQUITIES ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Nov 3, 2020 |
| JENSEN KLAVS F. PH.D. Director | -- | Direct | -- | Nov 3, 2020 |
| ARMON R. SHAREI IRREVOCABLE GST TRUST OF 2016 Trustee | -- | Direct | -- | Nov 3, 2020 |
Related Tickers
LIANY LianBio
0.3600
-5.14%
AVXT AVAX Technologies, Inc.
0.0001
+900.00%
GRTSQ Gritstone bio, Inc.
0.0000
0.00%
AFFY Affymax, Inc.
0.0024
+200.00%
TSBX Turnstone Biologics Corp.
0.3362
-2.72%
PTIXW Protagenic Therapeutics, Inc.
0.0598
0.00%
CALA Calithera Biosciences, Inc.
0.0001
-95.00%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
OTLC Oncotelic Therapeutics, Inc.
0.0479
-3.23%
THRD Third Harmonic Bio, Inc.
5.44
+0.09%